Anesthesiology · Little Rock, AR
NPI
1528055258
Since 2005
Specialty
Anesthesiology
Code 207L00000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
500 S University Ave Ste 214
Little Rock, AR, 72205
Phone (501) 476-3914
Groups this clinician bills Medicare through
Medicare paid, 2024
$257K
5,546 services
Medicare patients, 2024
836
Average age 71
Drug cost, 2024
$250K
10,723 prescriptions
Company payments, 2025
$1,102
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan C Roman was code 99214 (office e&m - established), 1,591 times for 643 patients. In total Juan C Roman billed 5,546 services in 49 codes, and Medicare paid $257K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,591 | 643 | $75.82 | $121K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 421 | 233 | $0.73 | $309 |
| 80305 Drug Tests | Office | 412 | 324 | $12.00 | $4,943 |
| 20610 Joint Injection | Office | 372 | 206 | $46.14 | $17K |
| 62323 Nerve Block Injection - Back | Facility | 252 | 201 | $61.13 | $15K |
| 64483 Nerve Block Injection - Back | Facility | 190 | 155 | $76.36 | $15K |
| 99152 Anesthesia | Facility | 178 | 146 | $7.65 | $1,362 |
| 62321 Nerve Block Injection - Back | Facility | 156 | 110 | $65.72 | $10K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 107 | 64 | $0.09 | $9.47 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 95 | 81 | $56.10 | $5,329 |
| 20552 Musculoskeletal | Office | 94 | 54 | $31.49 | $2,961 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 91 | 81 | $182.14 | $17K |
| 99204 Office E&M - New | Office | 80 | 80 | $97.48 | $7,799 |
| 64493 Nerve Block Injection - Back | Facility | 68 | 48 | $86.75 | $5,899 |
| 77002 Imaging - Miscellaneous | Facility | 68 | 60 | $22.47 | $1,528 |
By year: 2022 $275K for 6,045 services; 2023 $261K for 5,477 services; 2024 $257K for 5,546 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 412 | 324 | $12.00 | $4,943 |
Medicare prescription drug claims, 2024
In 2024, the drug Juan C Roman prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,245 prescriptions and refills. In total Juan C Roman wrote 10,723 Medicare prescriptions that cost $250K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,245 | 2,246 | 382 | $38K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,342 | 1,342 | 213 | $30K |
| Tizanidine Hcl Generic | 1,146 | 1,262 | 253 | $9,285 |
| Gabapentin Generic | 647 | 693 | 129 | $7,140 |
| Tramadol Hcl Generic | 606 | 610 | 193 | $3,720 |
| Cyclobenzaprine Hcl Generic | 402 | 424 | 87 | $1,740 |
| Duloxetine Hcl Generic | 319 | 421 | 69 | $3,848 |
| Meloxicam Generic | 315 | 362 | 77 | $893 |
| Pregabalin Generic | 310 | 335 | 77 | $6,389 |
| Zolpidem Tartrate Generic | 228 | 232 | 39 | $1,132 |
| Oxycodone Hcl Generic | 210 | 210 | 35 | $2,566 |
| Zaleplon Generic | 200 | 202 | 73 | $3,101 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 196 | 196 | 26 | $27K |
| Alprazolam Generic | 193 | 194 | 45 | $667 |
| Temazepam Generic | 173 | 173 | 27 | $1,272 |
Brand drugs: 169 claims; generic drugs: 10,554 claims; opioid claims: 4,633.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan C Roman $1,102 ($1,102 in general payments such as food, travel and fees) from 4 companies. The largest payer was Boston Scientific Corporation with $832.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.